Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment--report of 33 cases.
作者： Javier Perez-Rodriguez , Shenghan Lai , Benjamin D. Ehst , Derek M. Fine , David A. Bluemke
DOI: 10.1148/RADIOL.2502080498
关键词:
摘要: Purpose: To describe the presentation and clinical course of patients with nephrogenic systemic fibrosis (NSF) at a large acute-care hospital, to evaluate overall incidence NSF, assess effect hospital-wide policy regarding gadolinium-based contrast agent (GBCA) use on NSF incidence. Materials Methods: A review all cases observed an institution from 2003 2008 was conducted. This HIPAA-compliant study approved by institutional board. The informed consent requirement waived. Demographics, medical history, associated conditions were recorded. Radiologic procedures evaluated if they performed within 1 year prior onset. GBCA assessed checking electronic database for each procedure. compared before after implementation designed risk use. Results: All 33 (mean age, 49 years; age range, 15–78 years) had advanced re...
rsna.org
elsevier.com
rsnajnls.org参考文章(20)
Julian M. Mackay-Wiggan, David J. Cohen, Mark A. Hardy, Elizabeth H. Knobler, Marc E. Grossman, Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease). Journal of The American Academy of Dermatology. ,vol. 48, pp. 55- 60 ,(2003) , 10.1067/MJD.2003.78
Cynthia Kucher, Joanna Steere, Rosalie Elenitsas, Don L. Siegel, Xiaowei Xu, Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure Journal of the American Academy of Dermatology. ,vol. 54, pp. S31- S34 ,(2006) , 10.1016/J.JAAD.2005.04.024
Tomoya Saitoh, Kazumasa Hayasaka, Yoshiaki Tanaka, Tsutomu Kuno, Yuji Nagura, Dialyzability of gadodiamide in hemodialysis patients. Radiation Medicine. ,vol. 24, pp. 445- 451 ,(2006) , 10.1007/S11604-006-0055-9
J.A. Moreno-Romero, S. Segura, J.M. Mascaró, S.E. Cowper, M. Julià, E. Poch, A. Botey, C. Herrero, Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor. British Journal of Dermatology. ,vol. 157, pp. 783- 787 ,(2007) , 10.1111/J.1365-2133.2007.08067.X
Dale R. Broome, Mark S. Girguis, Pedro W. Baron, Alfred C. Cottrell, Ingrid Kjellin, Gerald A. Kirk, Gadodiamide-Associated Nephrogenic Systemic Fibrosis: Why Radiologists Should Be Concerned American Journal of Roentgenology. ,vol. 188, pp. 586- 592 ,(2007) , 10.2214/AJR.06.1094
Sumanth R. Daram, Cherise M. Cortese, Bahar Bastani, Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: report of a new case with literature review. American Journal of Kidney Diseases. ,vol. 46, pp. 754- 759 ,(2005) , 10.1053/J.AJKD.2005.06.024
Shawn E. Cowper, Nephrogenic systemic fibrosis: the nosological and conceptual evolution of nephrogenic fibrosing dermopathy. American Journal of Kidney Diseases. ,vol. 46, pp. 763- 765 ,(2005) , 10.1053/J.AJKD.2005.08.008
David J. Spinosa, Alan H. Matsumoto, J. Fritz Angle, Klaus D. Hagspiel, Ross B. Isaacs, Christopher S. McCullough, Peter I. Lobo, Gadolinium-based Contrast and Carbon Dioxide Angiography to Evaluate Renal Transplants for Vascular Causes of Renal Insufficiency and Accelerated Hypertension Journal of Vascular and Interventional Radiology. ,vol. 9, pp. 909- 916 ,(1998) , 10.1016/S1051-0443(98)70421-X
David J. Spinosa, Alan H. Matsumoto, J. Fritz Angle, Klaus D. Hagspiel, J. Kevin McGraw, Carlos Ayers, Renal Insufficiency: Usefulness of Gadodiamide-enhanced Renal Angiography to Supplement CO2-enhanced Renal Angiography for Diagnosis and Percutaneous Treatment Radiology. ,vol. 210, pp. 663- 672 ,(1999) , 10.1148/RADIOLOGY.210.3.R99FE58663
Elizabeth A. Sadowski, Lindsey K. Bennett, Micah R. Chan, Andrew L. Wentland, Andrea L. Garrett, Robert W. Garrett, Arjang Djamali, Nephrogenic Systemic Fibrosis: Risk Factors and Incidence Estimation Radiology. ,vol. 243, pp. 148- 157 ,(2007) , 10.1148/RADIOL.2431062144